ASND, GDS, ADSK and CDZI among after hours movers
9.28BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04351P1012
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-1.77
Dividend Share
-
Dividend Yield
-
Earnings Share
-6.84
Wall Street Target Price
203.79
EPS Estimate Current Year
-3.52
EPS Estimate Next Year
1.32
EPS Estimate Current Quarter
-0.9327
EPS Estimate Next Quarter
-1.3
Most Recent Quarter
-
Revenue TTM
363,640,992
Gross Profit TTM
319,383,008
EBITDA
-273,828,000
Profit Margin
-103.97%
Return On Assets TTM
-17.38%
Return On Equity TTM
-818.43%
Revenue Per Share TTM
6.281
Qtly Revenue Growth YOY
26.30%
Diluted Eps TTM
-6.84
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
25.4389
Price Book MRQ
14.5547
Enterprise Value Revenue
25
Enterprise Value EBITDA
-20
172.36
5.11%94.39
0.48%647.99
0.08%480.76
0.07%696.63
0.06%250.96
0.01%697.42
0.00%187.39
-1.37%82.73
-0.74%116.91
-0.73%